AGENUS INC Earnings Per Share, Basic and Diluted
AGENUS INC (AGEN) reported Earnings Per Share, Basic and Diluted of -$0.19 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-10
- AGENUS INC earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.19.
- AGENUS INC earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.37.
- AGENUS INC earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.27.
- AGENUS INC earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.20, a 366.72% decline year-over-year.
- AGENUS INC earnings per share, basic and diluted for fiscal 2021 was -$0.11.
- AGENUS INC earnings per share, basic and diluted for fiscal 2020 was -$1.05.
- AGENUS INC earnings per share, basic and diluted for fiscal 2019 was -$0.80.
- AGENUS INC earnings per share, basic and diluted for fiscal 2018 was -$1.44.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2022-03-31 | -$0.19 10-Q · filed 2022-05-10 | ||||
| 2021-12-31 | -$0.11 10-K · filed 2022-03-01 | ||||
| 2021-06-30 | -$0.37 10-Q · filed 2021-08-09 | -$0.65 10-Q · filed 2021-08-09 | $1.92 derived: net income ÷ weighted average shares · filed 2022-08-09 | $9.98 derived: net income ÷ weighted average shares · filed 2022-08-09 | |
| 2021-03-31 | -$0.27 10-Q · filed 2022-05-10 | $0.37 derived: net income ÷ weighted average shares · filed 2022-05-10 | $1.36 derived: net income ÷ weighted average shares · filed 2022-05-10 | $5.27 derived: net income ÷ weighted average shares · filed 2022-05-10 | |
| 2020-12-31 | -$0.20 10-K · filed 2021-03-16 | $0.57 derived: net income ÷ weighted average shares · filed 2022-03-01 | $2.83 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$1.05 10-K · filed 2022-03-01 | |
| 2020-09-30 | -$0.28 10-K · filed 2021-03-16 | -$0.56 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$0.87 10-Q · filed 2020-11-09 | -$7.28 derived: net income ÷ weighted average shares · filed 2022-03-01 | |
| 2020-06-30 | -$0.28 10-Q · filed 2021-08-09 | -$0.59 10-Q · filed 2021-08-09 | $4.20 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$13.35 derived: net income ÷ weighted average shares · filed 2022-03-01 | |
| 2020-03-31 | -$0.31 10-Q · filed 2021-05-07 | $0.58 derived: net income ÷ weighted average shares · filed 2022-03-01 | $3.04 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$43.26 derived: net income ÷ weighted average shares · filed 2022-03-01 | |
| 2019-12-31 | $0.07 derived: net income ÷ weighted average shares · filed 2022-03-01 | $0.57 derived: net income ÷ weighted average shares · filed 2022-03-01 | $2.93 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$0.80 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$0.33 10-Q · filed 2020-11-09 | -$0.71 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$0.58 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | -$0.38 10-Q · filed 2020-08-10 | -$0.24 10-Q · filed 2020-08-10 | |||
| 2018-12-31 | -$0.40 10-K · filed 2020-03-16 | $0.78 derived: net income ÷ weighted average shares · filed 2021-03-16 | $3.10 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$1.44 10-K · filed 2021-03-16 | |
| 2018-09-30 | -$0.37 10-K · filed 2020-03-16 | -$0.29 10-Q · filed 2018-11-07 | -$0.53 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$1.04 10-Q · filed 2019-11-07 | -$19.37 derived: net income ÷ weighted average shares · filed 2020-03-16 |
| 2018-06-30 | -$0.24 10-K · filed 2020-03-16 | -$0.76 10-Q · filed 2019-08-09 | $4.04 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$39.44 derived: net income ÷ weighted average shares · filed 2020-03-16 | |
| 2018-03-31 | -$0.53 10-K · filed 2020-03-16 | $0.94 derived: net income ÷ weighted average shares · filed 2020-03-16 | $4.21 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$67.27 derived: net income ÷ weighted average shares · filed 2020-03-16 | |
| 2017-12-31 | -$0.35 10-K · filed 2019-03-18 | $0.75 derived: net income ÷ weighted average shares · filed 2020-03-16 | $3.34 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$1.23 10-K · filed 2020-03-16 | |
| 2017-09-30 | -$0.37 10-K · filed 2019-03-18 | -$0.69 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$0.88 10-Q · filed 2018-11-07 | -$1.18 derived: net income ÷ weighted average shares · filed 2019-03-18 | |
| 2017-06-30 | -$0.32 10-K · filed 2019-03-18 | -$0.51 10-Q · filed 2018-08-09 | -$0.80 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$1.26 derived: net income ÷ weighted average shares · filed 2019-03-18 | |
| 2017-03-31 | -$0.18 10-K · filed 2019-03-18 | -$0.48 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$0.94 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$1.27 derived: net income ÷ weighted average shares · filed 2019-03-18 | |
| 2016-12-31 | -$0.30 10-K · filed 2018-03-16 | -$0.77 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$1.09 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$1.46 10-K · filed 2019-03-18 | |
| 2016-09-30 | -$0.47 10-K · filed 2018-03-16 | -$0.79 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$1.16 10-Q · filed 2017-11-07 | -$1.35 derived: net income ÷ weighted average shares · filed 2018-03-16 | |
| 2016-06-30 | -$0.33 10-K · filed 2018-03-16 | -$0.69 10-Q · filed 2017-08-07 | -$0.88 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$1.04 derived: net income ÷ weighted average shares · filed 2018-03-16 | |
| 2016-03-31 | -$0.37 10-K · filed 2018-03-16 | -$0.55 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$0.71 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$1.22 derived: net income ÷ weighted average shares · filed 2018-03-16 | |
| 2015-12-31 | -$0.18 10-K · filed 2017-03-16 | -$0.34 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$0.85 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$1.13 10-K · filed 2018-03-16 | |
| 2015-09-30 | -$0.16 10-K · filed 2017-03-16 | -$0.67 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$0.95 10-Q · filed 2016-11-09 | -$1.36 derived: net income ÷ weighted average shares · filed 2017-03-16 | |
| 2015-06-30 | -$0.53 10-K · filed 2017-03-16 | -$0.83 10-Q · filed 2016-08-04 | -$1.24 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$1.39 derived: net income ÷ weighted average shares · filed 2017-03-16 | |
| 2015-03-31 | -$0.28 10-K · filed 2017-03-16 | -$0.69 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$0.83 derived: net income ÷ weighted average shares · filed 2017-03-16 | ||
| 2014-12-31 | -$0.41 10-K · filed 2016-03-15 | -$0.54 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$0.71 10-K · filed 2017-03-16 | ||
| 2014-09-30 | -$0.13 10-K · filed 2016-03-15 | -$0.28 10-Q · filed 2015-11-04 | |||
| 2014-06-30 | -$0.13 10-K · filed 2016-03-15 | ||||
| 2014-03-31 | -$0.01 10-K · filed 2016-03-15 | ||||
| 2013-12-31 | -$0.16 10-K · filed 2015-03-16 | -$1.12 10-K · filed 2016-03-15 | |||
| 2013-09-30 | -$0.24 10-K · filed 2015-03-16 | ||||
| 2013-06-30 | -$0.40 10-K · filed 2015-03-16 | ||||
| 2013-03-31 | -$0.35 10-K · filed 2015-03-16 | ||||
| 2012-12-31 | -$0.23 10-K · filed 2014-03-07 | -$0.51 10-K · filed 2015-03-16 | |||
| 2012-09-30 | -$0.24 10-K · filed 2014-03-07 | -$0.28 10-Q · filed 2012-11-07 | |||
| 2012-06-30 | -$0.31 10-K · filed 2014-03-07 | -$0.02 10-Q · filed 2012-08-08 | |||
| 2012-03-31 | $0.29 10-K · filed 2014-03-07 | ||||
| 2011-12-31 | -$0.29 10-K · filed 2013-03-18 | -$1.21 10-K · filed 2014-03-07 | |||
| 2011-09-30 | -$0.28 10-K · filed 2013-03-18 | -$0.92 10-Q · filed 2012-11-07 | |||
| 2011-06-30 | -$0.31 10-K · filed 2013-03-18 | -$0.64 10-Q · filed 2012-08-08 | |||
| 2011-03-31 | -$0.33 10-K · filed 2013-03-18 | ||||
| 2010-12-31 | -$1.41 10-K · filed 2013-03-18 | ||||
| 2009-12-31 | -$2.36 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |